Literature DB >> 11597927

Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice.

M M Véniant1, S Withycombe, S G Young.   

Abstract

Two hypercholesterolemic mouse models, the apo-E-deficient mouse (Apoe(-/-)) and the LDL receptor-deficient mouse (Ldlr(-/-)), have been used extensively as animal models of atherogenesis. Total plasma cholesterol levels in chow-fed Apoe(-/-) mice are much higher than in Ldlr(-/-) mice. In a recent study, we managed to even-up the cholesterol levels in Apoe(-/-) mice and Ldlr(-/-) mice by making both models homozygous for the Apob(100) (apo B-100-only) allele. On a chow diet, apo-E-deficient apo B-100-only mice (Apoe(-/-)Apob(100/100)) and LDL receptor-deficient apo B-100-only mice (Ldlr(-/-)Apob(100/100)) had similar total plasma cholesterol levels ( approximately 300 mg/dL). The plasma of Ldlr(-/-)Apob(100/100) mice contained large numbers of small lipoproteins, whereas the plasma of Apoe(-/-)Apob(100/100) mice contained much lower levels of much larger lipoproteins. Interestingly, the Ldlr(-/-)Apob(100/100) mice developed far more extensive atherosclerotic lesions than the Apoe(-/-)Apob(100/100) mice. The finding of substantially more atherosclerosis in Ldlr(-/-)Apob(100/100) mice than in Apoe(-/-)Apob(100/100) mice, despite nearly identical cholesterol levels, suggests that large numbers of small apo B-100-containing lipoproteins are far more atherogenic than lower numbers of large apo B-100-containing lipoproteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11597927     DOI: 10.1161/hq1001.097780

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  36 in total

1.  Notch signaling regulates endothelial progenitor cell activity during recovery from arterial injury in hypercholesterolemic mice.

Authors:  Masaaki Ii; Kyosuke Takeshita; Kayoko Ibusuki; Corinne Luedemann; Andrea Wecker; Elizabeth Eaton; Tina Thorne; Takayuki Asahara; James K Liao; Douglas W Losordo
Journal:  Circulation       Date:  2010-02-22       Impact factor: 29.690

2.  Is hypercholesterolemia a friend or a foe of tuberculosis?

Authors:  Runlin Han; Hardy Kornfeld; Gregory Martens
Journal:  Infect Immun       Date:  2009-08       Impact factor: 3.441

3.  Impact of Inhibiting Ileal Apical versus Basolateral Bile Acid Transport on Cholesterol Metabolism and Atherosclerosis in Mice.

Authors:  Paul A Dawson
Journal:  Dig Dis       Date:  2015-05-27       Impact factor: 2.404

4.  Activation of the TLR4 signaling pathway and abnormal cholesterol efflux lead to emphysema in ApoE-deficient mice.

Authors:  Monica Goldklang; Polina Golovatch; Tina Zelonina; Jordis Trischler; Daniel Rabinowitz; Vincent Lemaître; Jeanine D'Armiento
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-23       Impact factor: 5.464

5.  CD11c/CD18 Signals Very Late Antigen-4 Activation To Initiate Foamy Monocyte Recruitment during the Onset of Hypercholesterolemia.

Authors:  Greg A Foster; Lu Xu; Alagu A Chidambaram; Stephanie R Soderberg; Ehrin J Armstrong; Huaizhu Wu; Scott I Simon
Journal:  J Immunol       Date:  2015-10-30       Impact factor: 5.422

Review 6.  Animal models of atherosclerosis.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-01       Impact factor: 8.311

7.  Pressure overload leads to coronary plaque formation, progression, and myocardial events in ApoE-/- mice.

Authors:  Alice Marino; Yi Zhang; Luisa Rubinelli; Maria Antonietta Riemma; James E Ip; Annarita Di Lorenzo
Journal:  JCI Insight       Date:  2019-05-02

Review 8.  Sex differences in stroke.

Authors:  Roy A M Haast; Deborah R Gustafson; Amanda J Kiliaan
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-03       Impact factor: 6.200

9.  Nitric oxide-releasing agent, LA419, reduces atherogenesis in apolipoprotein E-deficient mice.

Authors:  Ricardo Carnicer; Natalia Guillén; José M Arbonés-Mainar; María A Navarro; Mario A Guzmán; Cristina Barranquero; Carmen Arnal; Sonia Gascón; Sergio Acín; Marisabel Mourelle; Jesús Osada
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-12-03       Impact factor: 3.000

10.  VASCULAR INFLAMMATION AND ATHEROGENESIS ARE ACTIVATED VIA RECEPTORS FOR PAMPs AND SUPPRESSED BY REGULATORY T CELLS.

Authors:  Xiao-Feng Yang; Ying Yin; Hong Wang
Journal:  Drug Discov Today Ther Strateg       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.